The Neuroendocrine Tumors market is witnessing robust industry growth driven by advancements in targeted therapies and increasing diagnostic capabilities. The market’s evolution is shaped by breakthroughs in immunotherapy and personalized medicine, making it a dynamic sector with substantial business growth opportunities from 2026 onward.Market Size and OverviewThe Global Neuroendocrine...